Skip to content

SureGlide 35BXRecalls & reported problems

Gyrus ACMI, LLC · Guidewire 0.035" (0.89 mm) x 150 cm Regular Body, 3 cm Straight Tip (5/PK) · Class 1

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00821925005730), received between Jun 16, 2021 and Nov 11, 2024 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Detachment of Device or Device Component1
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Foreign Body In Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 11, 2024Break; Detachment of Device or Device Component; Break; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING AN UNKNOWN PROCEDURE, APPROXIMATELY 0.5CM PIECE OF THE LINING OF A GUIDE WIRE BROKE OFF FROM THE GUIDE WIRE AND WAS IN THE PATIENT'S BODY, UNTIL THE SURGEON REMOVED IT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20658923 ↗
  • MalfunctionOct 15, 2024

    APPROXIMATELY 0.5CM PIECE OF THE LINING OF A GUIDE WIRE BROKE OFF FROM THE GUIDE WIRE AND WAS IN THE PATIENT'S BODY, UNTIL THE SURGEON REMOVED IT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20450930 ↗
  • InjuryJun 16, 2021Material Separation; Material Separation

    IT IS REPORTED A PATIENT HAD A LEFT URETEROSCOPY WITH STENT FOR THE INDICATION OF LEFT URETERAL STONE (B)(6) 2020 USING A SURE GLIDE GUIDEWIRE AND AN HOLMIUM LASER (THE LASER SETTINGS WERE: 800 MJ AND 8 HZ. JOULES: 263.20, PULSES: 329, DURATION: 41 SECONDS). AFTER THE PROCEDURE, THE PATIENT EXPERIENCED URINARY URGENCY, FREQUENCY, AND URETHRAL PAIN. AN UNSPECIFIED TIME LATER, THE PATIENT HAD AN ULTRASOUND AND IT WAS FOUND THAT THE PATIENT HAD RETAINED A PORTION OF THE WIRE. THE PATIENT HAD ANOTHER URETEROSCOPY PROCEDURE (B)(6) 2021 TO TRY TO RETRIEVE THE BROKEN GUIDEWIRE WITH NO SUCCESS. THE PATIENT WAS THEN BOOKED FOR A LOWER URETERAL POLE STENT, UPPER POLE URETER URETEROSCOPY, REMOVAL OF FOREIGN BODY IN THE DISTAL URETER OF THE UPPER POLE URETER, URETERAL STENT IN UPPER POLE URETER AND REMOVAL OF STENT IN LOWER POLE AT THE LOCAL HOSPITAL TO HAVE THE DEVICE FRAGMENT REMOVED (B)(6) 2021 WHICH WAS SUCCESSFUL. THE PATIENT HAD A STENT PLACED AND CAME BACK SEVERAL WEEKS LATER TO HAVE THE STENT REMOVED AND IS NOW DOING FINE. NO FURTHER PROBLEMS. THE DEVICE FRAGMENT THAT WAS REMOVED FROM THE PATIENT WAS SENT TO PATHOLOGY. IT MEASURED 3.6CM X 0.1CM AND CAME BACK AS HYDROPHILIC NITINOL CORE

    Patient problems: Foreign Body In Patient

    MAUDE report 12014265 ↗

Other STYLET, URETERAL devices

All STYLET, URETERAL devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.